[go: up one dir, main page]

NO20055393L - Oralt desintegrerende tabletter - Google Patents

Oralt desintegrerende tabletter

Info

Publication number
NO20055393L
NO20055393L NO20055393A NO20055393A NO20055393L NO 20055393 L NO20055393 L NO 20055393L NO 20055393 A NO20055393 A NO 20055393A NO 20055393 A NO20055393 A NO 20055393A NO 20055393 L NO20055393 L NO 20055393L
Authority
NO
Norway
Prior art keywords
orally disintegrating
disintegrating tablets
microcrystalline cellulose
tablet
effective amount
Prior art date
Application number
NO20055393A
Other languages
English (en)
Other versions
NO20055393D0 (no
Inventor
Johannes Jan Platteeuw
Dennie Johan Marijn Van Heuvel
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of NO20055393D0 publication Critical patent/NO20055393D0/no
Publication of NO20055393L publication Critical patent/NO20055393L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Silisifisert mikrokrystallinsk cellulose anvendes for å tilveiebringe en tablett med oral desintegrasjon. Tabletten inneholder minst 30 % av den sihsifiserte mikrokrystallinske cellulosen og en effektiv mengde av et farmasøytisk aktiv middel.
NO20055393A 2003-04-16 2005-11-15 Oralt desintegrerende tabletter NO20055393L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46302703P 2003-04-16 2003-04-16
PCT/EP2004/004119 WO2004091585A1 (en) 2003-04-16 2004-04-16 Orally disintegrating tablets

Publications (2)

Publication Number Publication Date
NO20055393D0 NO20055393D0 (no) 2005-11-15
NO20055393L true NO20055393L (no) 2006-01-16

Family

ID=33300032

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055393A NO20055393L (no) 2003-04-16 2005-11-15 Oralt desintegrerende tabletter

Country Status (10)

Country Link
US (1) US20040265375A1 (no)
EP (1) EP1613289A1 (no)
JP (1) JP2006524650A (no)
CN (1) CN1787811A (no)
AU (1) AU2004229177A1 (no)
CA (1) CA2522100A1 (no)
NO (1) NO20055393L (no)
NZ (1) NZ542925A (no)
WO (1) WO2004091585A1 (no)
ZA (1) ZA200508361B (no)

Families Citing this family (118)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
PT1243262E (pt) 2001-03-20 2006-10-31 Sanol Arznei Schwarz Gmbh Nova utilizacao de uma classe de compostos peptideos para o tratamento da dor inflamatoria nao neuropatica
DE60100055T2 (de) 2001-03-21 2003-07-24 Schwarz Pharma Ag Neue Verwendung einer Klasse von Peptidverbindungen zur Behandlung von Allodynie oder andere Arten von chronischen oder Phantomschmerzen
US20040161459A1 (en) * 2002-12-31 2004-08-19 Ngoc Do Fast-dissolve tablet technology
CA2540040C (en) * 2003-10-07 2012-09-11 Andrx Pharmaceuticals Llc Rapidly disintegrating formulation
EP1678139B1 (en) * 2003-10-10 2011-08-31 Synhton B.V. Solid-state montelukast
CZ300438B6 (cs) * 2003-11-25 2009-05-20 Pliva Hrvatska D.O.O. Zpusob prípravy orální pevné lékové formy s okamžitým uvolnováním úcinné látky obsahující jako úcinnou látku polymorfní formu finasteridu
WO2005070938A1 (en) * 2004-01-27 2005-08-04 Synthon B.V. Stable salts of olanzapine
US20050272720A1 (en) * 2004-01-27 2005-12-08 Rolf Keltjens Process for making olanzapine Form I
EP1715853A4 (en) 2004-02-17 2012-07-18 Transcept Pharmaceuticals Inc COMPOSITIONS FOR THE DISTRIBUTION OF HYPNOTICS IN THE FIELD OF MUNICHCHLEIMHÄUTE AND USE METHOD THEREOF
US7501517B2 (en) * 2004-04-30 2009-03-10 Synthon Ip, Inc. Process for making montelukast and intermediates therefor
US7829716B2 (en) * 2004-04-30 2010-11-09 Synthon Pharmaceuticals, Inc. Process for making montelukast and intermediates therefor
DE102004028940A1 (de) * 2004-06-15 2006-01-12 Krka Tovarna Zdravil, D.D. Oral zerfallende pharmazeutische Zusammensetzung, die Risperidon enthält
EA014055B1 (ru) 2004-08-27 2010-08-30 Шварц Фарма Аг Применение пептидных соединений для лечения боли при раке кости, а также боли, вызванной химиотерапией и нуклеозидами
US20060078615A1 (en) * 2004-10-12 2006-04-13 Boehringer Ingelheim International Gmbh Bilayer tablet of telmisartan and simvastatin
EP2283811A1 (en) 2004-10-19 2011-02-16 Krka Tovarna Zdravil, D.D., Novo Mesto Solid pharmaceutical composition comprising donepezil hydrochloride
GB0423800D0 (en) * 2004-10-27 2004-12-01 Orexo Ab New pharmaceutical formulations
AU2005315291A1 (en) * 2004-12-13 2006-06-22 Mcneil-Ppc, Inc. Compositions and methods for stabilizing active pharmaceutical ingredients
KR100866720B1 (ko) 2004-12-27 2008-11-05 에자이 알앤드디 매니지먼트 가부시키가이샤 항치매 약물의 안정화 방법
CZ200563A3 (cs) * 2005-02-02 2006-10-11 Zentiva, A. S. Lécivý prípravek obsahující jako úcinnou slozku olanzapin a zpusob jeho výroby
IS7724A (is) * 2005-03-02 2006-09-03 Actavis Group Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
US20060240101A1 (en) * 2005-04-22 2006-10-26 Shubha Chungi Orally disintegrating pharmaceutical tablet formulations of olanzapine
US20070123562A1 (en) 2005-05-25 2007-05-31 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the-night insomnia
ZA200710205B (en) * 2005-05-25 2009-03-25 Transcept Pharmaceuticals Inc Solid compositions and methods for treating middle-of-the night insomnia
US20070287740A1 (en) 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
WO2007002518A1 (en) * 2005-06-23 2007-01-04 Spherics, Inc. Delayed release or extended-delayed release dosage forms of pramipexole
JP2007015966A (ja) * 2005-07-06 2007-01-25 Fujimoto Corporation:Kk 口腔内崩壊錠
DE102005033943A1 (de) * 2005-07-20 2007-02-22 Hexal Ag Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum
JP4439499B2 (ja) * 2005-08-01 2010-03-24 大日本住友製薬株式会社 アムロジピン含有粒子およびそれからなる口腔内崩壊錠
JP5241681B2 (ja) * 2005-08-01 2013-07-17 大日本住友製薬株式会社 アムロジピン含有粒子およびそれからなる口腔内崩壊錠
JP5366233B2 (ja) * 2005-08-10 2013-12-11 塩野義製薬株式会社 口腔内崩壊錠剤
EP1919923A1 (en) * 2005-08-17 2008-05-14 Synthon B.V. A process for making olanzapine form i
WO2007020079A2 (en) * 2005-08-17 2007-02-22 Synthon B.V. Orally disintegratable simvastatin tablets
GB0518129D0 (en) * 2005-09-06 2005-10-12 Arrow Int Ltd Ramipril formulation
FR2891147B1 (fr) 2005-09-28 2007-12-07 Ethypharm Sa Comprimes orodispersibles de principes actifs amers
US20070093471A1 (en) * 2005-10-26 2007-04-26 Alamo Pharmaceuticals, Llc Compositions and methods for the administration clozapine formulations which modulate body weight
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
AR057909A1 (es) * 2005-11-18 2007-12-26 Synthon Bv Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico.
EP1948132B1 (en) * 2005-11-18 2009-08-05 Synhton B.V. Zolpidem tablets
DE102005060377A1 (de) * 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
JP2009519334A (ja) * 2005-12-20 2009-05-14 テバ ファーマシューティカル インダストリーズ リミティド ランソプラゾール経口崩壊錠剤
WO2007071420A1 (en) * 2005-12-23 2007-06-28 Lek Pharmaceuticals D.D. Bursting pellets
EP1976522B2 (en) † 2005-12-30 2019-07-03 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition containing montelukast
AU2007211091B8 (en) * 2006-01-27 2013-08-29 Adare Pharmaceuticals, Inc. Drug delivery systems comprising weakly basic selective serotonin 5-HT3 blocking agent and organic acids
KR20140088230A (ko) * 2006-01-27 2014-07-09 앱탈리스 파마테크, 인코포레이티드 약 염기성 약물과 유기산을 포함하는 약물 전달 시스템
EP1815857A1 (en) * 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
CN101432267A (zh) * 2006-03-17 2009-05-13 斯索恩有限公司 孟鲁司特金刚烷胺盐
SG170766A1 (en) * 2006-03-24 2011-05-30 Kowa Co Oral fast-disintegrating tablet
US20070293479A1 (en) * 2006-05-18 2007-12-20 Osinga Niels J Olanzapine pharmaceutical composition
US20070281014A1 (en) * 2006-06-01 2007-12-06 Cima Labs, Inc. Prednisolone salt formulations
US8637076B2 (en) * 2006-06-01 2014-01-28 Cima Labs Inc. Prednisolone salt formulations
WO2007144195A2 (en) 2006-06-15 2007-12-21 Schwarz Pharma Ag Pharmaceutical composition with synergistic anticonvulsant effect
EP2040676A2 (en) * 2006-07-06 2009-04-01 Forest Laboratories, Inc. Orally dissolving formulations of memantine
JP2008044870A (ja) * 2006-08-11 2008-02-28 Elmed Eisai Kk 医薬組成物及びその製造方法
AR063043A1 (es) * 2006-09-29 2008-12-23 Synthon Bv Composicion farmaceutica de olanzapina
WO2008058355A2 (en) * 2006-11-16 2008-05-22 Walter Santos Junior Descriptive report of patent of invention of the medicament 'atorvastatin + metformin' in combined form for cardiovascular diseases
BRMU8602968U (pt) * 2006-11-16 2008-09-30 Jr Walter Santos medicamento "ramipril + metformina" em forma combinada para doenças cardiovasculares
GB2444904B (en) * 2006-12-05 2008-11-05 Michael Hilary Burke A Process For The Preparation of an Orally Administrable Unit Dose Tablet
JP5275815B2 (ja) * 2006-12-26 2013-08-28 塩野義製薬株式会社 リスペリドンを含有する口腔内崩壊錠剤および苦味抑制製剤
CN101269014B (zh) * 2007-03-21 2012-11-14 江苏万特制药有限公司 一种利培酮的口腔崩解片及其制备方法
EP2148659A2 (en) 2007-04-13 2010-02-03 Somaxon Pharmaceuticals, Inc. Low-dose doxepin formulations
EP1997480A1 (en) * 2007-06-01 2008-12-03 The Jordanian Pharmaceutical Manufacturing Co. Mineral-fiber solid dispersion, method for preparing the same and use thereof as pharmaceutical tableting aid
TWI547282B (zh) 2007-07-02 2016-09-01 愛戴爾製藥股份有限公司 樂命達之口服分解錠劑組合物
EP2044929A1 (en) * 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Oral fast distintegrating tablets
JP5409382B2 (ja) * 2007-11-21 2014-02-05 大日本住友製薬株式会社 口腔内崩壊錠
JP2011506279A (ja) * 2007-12-08 2011-03-03 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト 経口で分散可能な錠剤
JP2009196940A (ja) * 2008-02-22 2009-09-03 Takada Seiyaku Kk 口腔内速崩壊錠及びその製造法
CN102046602A (zh) * 2008-04-25 2011-05-04 斯索恩有限公司 制备孟鲁司特中间体的方法
US20100016265A1 (en) * 2008-07-16 2010-01-21 Qaiser Yusuf Anti-inflammatory composition and method for preparation
CN101766605B (zh) * 2008-12-29 2014-02-19 北京德众万全药物技术开发有限公司 包含普拉克索的可在口中分散的药物组合物
US20120077888A1 (en) 2009-03-26 2012-03-29 Royal College Of Surgeons In Ireland Orodispersible tablets
TR200903293A1 (tr) * 2009-04-28 2010-11-22 Sanovel İlaç San. Ve Ti̇c. A.Ş. Oral yolla dağılan olanzapin tablet.
WO2010144865A2 (en) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
KR101074271B1 (ko) * 2009-06-25 2011-10-17 (주)차바이오앤디오스텍 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름
US20110003005A1 (en) * 2009-07-06 2011-01-06 Gopi Venkatesh Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
EP2477609A1 (en) * 2009-09-15 2012-07-25 Ratiopharm GmbH Orally disintegrating pharmaceutical dosage form containing aripiprazole
PT3403654T (pt) 2009-10-01 2019-09-05 Adare Dev I L P Composições de corticosteroide administradas oralmente
TR200907554A1 (tr) * 2009-10-06 2011-04-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Oral yolla dağılan pramıpexole bileşimleri.
CN102058549B (zh) * 2009-11-17 2014-08-27 北京万全阳光医学技术有限公司 一种含非那雄胺的口腔崩解片及其制备方法
CN101716151B (zh) * 2009-12-24 2012-06-27 杭州康恩贝制药有限公司 一种快速溶出的非那雄胺口服片剂及制备方法
EP2524689B1 (en) * 2009-12-28 2016-10-05 Nipro Corporation Method for producing donepezil tablets
JP2011213695A (ja) * 2010-04-02 2011-10-27 Taisho Pharm Ind Ltd ドネペジル塩酸塩含有口腔内速崩壊錠
EP2590630B1 (en) * 2010-07-08 2015-04-29 ratiopharm GmbH Oral dosage form of deferasirox
WO2012060847A1 (en) * 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis
EP2468254A1 (en) * 2010-12-15 2012-06-27 Hexal AG Orally disintegrating tablet having a taste masking effect
CN102727452B (zh) * 2011-04-01 2014-12-24 成都康弘药业集团股份有限公司 一种含右佐匹克隆的颗粒及其制备方法
WO2013095314A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Pharmaceutical formulations comprising risperidone
JP6062693B2 (ja) * 2012-09-14 2017-01-18 沢井製薬株式会社 オランザピン含有製剤
WO2014090386A1 (en) * 2012-12-11 2014-06-19 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Orally disintegrating tablet containing asenapine
US20160000714A1 (en) 2013-03-06 2016-01-07 Capsugel Belgium Nv Curcumin solid lipid particles and methods for their preparation and use
US20150025112A1 (en) * 2013-07-19 2015-01-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Orally disintegrating tablet formulations of donepezil
WO2015034678A2 (en) * 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
TN2016000197A1 (en) * 2013-11-22 2017-10-06 Genzyme Corp Novel methods for treating neurodegenerative diseases.
CN104784047B (zh) * 2014-01-16 2018-09-21 南京瑞尔医药有限公司 一种非那雄胺组合物
CN105012253A (zh) * 2014-04-24 2015-11-04 南京长澳医药科技有限公司 一种盐酸普拉克索口腔崩解片及其制备方法
EP3766480A1 (en) * 2014-06-10 2021-01-20 Capsugel Belgium NV Orally disintegrating tablet containing solid lipid particles and methods for their preparation and use
CN104027319A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 一种塞来昔布分散片及其制备方法
JP6566450B2 (ja) 2014-09-17 2019-08-28 ステアライフ・インディア・プライベート・リミテッド 発泡組成物及びそれを製造する方法
JP2016079120A (ja) * 2014-10-15 2016-05-16 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 包装により安定性が改善されたオランザピン製剤
CN104382895A (zh) * 2014-10-22 2015-03-04 湖南明瑞制药有限公司 一种辛伐他汀组合物
CN104523645A (zh) * 2014-11-20 2015-04-22 美吉斯制药（厦门）有限公司 甲磺酸帕罗西汀片芯及其包衣片的制备方法
WO2016087261A1 (en) 2014-12-04 2016-06-09 Capsugel Belgium N.V. Lipid multiparticulate formulations
EP3238712B1 (en) * 2014-12-25 2023-11-01 Daicel Corporation Very rapidly disintegrating tablet, and method for producing same
CN104771761A (zh) * 2015-03-19 2015-07-15 深圳国源国药有限公司 一种创新药用辅料硅化微晶纤维素及其制备方法
CN105147627B (zh) * 2015-08-19 2019-04-12 天津红日药业股份有限公司 一种含有盐酸普拉克索的药物组合物及其制备方法
US11219594B2 (en) 2015-12-12 2022-01-11 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
RU2619213C1 (ru) * 2016-01-25 2017-05-12 Закрытое Акционерное Общество "БИОКОМ" Твердая лекарственная форма зафирлукаста немедленного высвобождения и способ ее получения
US11173098B1 (en) 2016-02-05 2021-11-16 Gram Tactical Llc Magazines for tactical medicine dispensers
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
CN108938580B (zh) * 2017-05-26 2022-09-27 万全万特制药江苏有限公司 盐酸帕罗西汀口崩片
CN109864975B (zh) * 2017-12-04 2021-10-08 成都康弘药业集团股份有限公司 一种阿立哌唑的口腔崩解片及其制备方法
CN111757728A (zh) * 2018-03-11 2020-10-09 纳诺洛吉卡股份公司 用于压缩的药物剂型的多孔二氧化硅颗粒
CN110840850B (zh) * 2018-07-24 2023-03-17 烟台药物研究所 一种高生物利用度的塞来昔布冻干口崩片及其制备方法
WO2020049505A1 (en) 2018-09-06 2020-03-12 Innopharmascreen Inc. Methods and compositions for treatment of asthma or parkinson's disease
JP7219979B2 (ja) * 2020-02-26 2023-02-09 日新製薬株式会社 被覆層を有する口腔内崩壊錠
GB2636158A (en) * 2023-12-01 2025-06-11 Novumgen Ltd An orally disintegrating tablet containing amlodipine or pharmaceutically acceptable salts thereof and the process of preparing the same
GB2636182A (en) * 2023-12-04 2025-06-11 Novumgen Ltd An orally disintegrating tablet of paroxetine and its process of preparation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US50312A (en) * 1865-10-03 Improvement in handle attachments to small-arms
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6471994B1 (en) * 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
DE19530575A1 (de) * 1995-08-19 1997-02-20 Gruenenthal Gmbh Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
WO1999059544A2 (en) * 1998-05-18 1999-11-25 Takeda Chemical Industries, Ltd. Orally disintegrable tablets
WO1999063969A1 (en) * 1998-06-08 1999-12-16 Groenewoud Pieter J Stabilized thyroxine medications
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
HUP0301333A3 (en) * 1999-12-06 2005-06-28 Penwest Pharmaceuticals Co Sea Pharmaceutical superdisintegrant, process for its preparation and its use
US6399101B1 (en) * 2000-03-30 2002-06-04 Mova Pharmaceutical Corp. Stable thyroid hormone preparations and method of making same
AU2002355624B2 (en) * 2001-07-31 2006-02-02 H. Lundbeck A/S Crystalline composition containing escitalopram
BR0307516A (pt) * 2002-02-01 2004-12-07 Pfizer Prod Inc Formas de dosagem de liberação imediata contendo dispersões de uma droga sólida
SI21221A (sl) * 2002-06-21 2003-12-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Hitro razpadljive tablete

Also Published As

Publication number Publication date
CN1787811A (zh) 2006-06-14
NO20055393D0 (no) 2005-11-15
NZ542925A (en) 2007-04-27
US20040265375A1 (en) 2004-12-30
EP1613289A1 (en) 2006-01-11
WO2004091585A1 (en) 2004-10-28
ZA200508361B (en) 2006-12-27
AU2004229177A1 (en) 2004-10-28
JP2006524650A (ja) 2006-11-02
CA2522100A1 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
NO20055393L (no) Oralt desintegrerende tabletter
EA200000246A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
WO2004000197A3 (en) Quick dissolve compositions and tablets based thereon
NO20045434L (no) En kombinasjon av en NMDA-antagonist og acetylkolinesteraseinhibitorer for behandlingen av Alzheimers sykdom
TW200633730A (en) Oral disintegrating dosage forms
NO20065390L (no) Farmasoytisk preparat i fast enhetsdoseringsform
TR200002207T1 (tr) Slekoksib bileşikleri.
NZ507566A (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
ATE350040T1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin
AU3846901A (en) Oral, nasal and pulmonary dosage formualtions of copolymer 1
DE69620606D1 (de) Feste oral anzuwendende arzeneiform
DE69838300D1 (de) Pharmazeutische suspensionstabletten-zusammenstellungen
MXPA04005105A (es) Formulaciones de acitromicina directamente compresibles.
AR053440A2 (es) Uso de una forma de dosificacion farmaceutica de liberacion sostenida para la manufactura de un medicamento, dicha forma de dosificacion farmaceutica y una tableta comprimida
CA2505964A1 (en) Pharmaceutical compositions and dosage forms of thalidomide
HUP0102676A2 (hu) Szilárd, gyorsan széteső cetirizint tartalmazó gyógyszerkészítmények
PE20000559A1 (es) Formulacion de tabletas comprimidas de efavirenz
AP2004002999A0 (en) Organoleptically acceptable intraorally disintegrating compositions
EA200800880A1 (ru) Комбинация росиглитазона и донепезила, предназначенная для улучшения когнитивной функции
HUP0402577A2 (hu) Citoszol foszfolipáz A2 inhibitor hatású indolszármazékok, eljárás előállításukra
MXPA04003346A (es) Formulacion de dosis oral de disolucion instantanea.
HUP0203148A2 (hu) Mirtazapint tartalmazó orálisan dezintegrálódó készítmény
DE602004004782D1 (de) Schnell wasserdispergierbare und Domperidon enthaltende Tabletten
AR038305A1 (es) Composicion farmaceutica dispersable oralmente de perindopril
AR038206A1 (es) Composicion farmaceutica dispersable oralmente de ivabradina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application